Stock PBH PRESTIGE CONSUMER HEALTHCARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Prestige Consumer Healthcare Inc.

Equities

PBH

US74112D1019

Market Closed - Nyse
Other stock markets
 01:30:01 27/04/2024 am IST 		5-day change 1st Jan Change
70.47 USD +0.47% Intraday chart for Prestige Consumer Healthcare Inc. +1.15% +15.11%
16/02 Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing MT
16/02 Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing MT

Evolution of the average Target Price on Prestige Consumer Healthcare Inc.

Price target over the last 5 years

History of analyst recommendation changes

90df1d5cf.KEox_c1cJtBZo4OPKYzU90Cl7KKSKzaiRJroS0VViWA.eDxap6MMYZ0D7c7DH92NgjbQtc3nWFztAcK-AwsYuDhZIkWngS9QlivQ9A~47f2e0116d655996a29e916de2e24d8d

Analyst Recommendations on Prestige Consumer Healthcare Inc.

Oppenheimer Adjusts Prestige Consumer Healthcare's Price Target to $71 From $72, Maintains Outperform Rating MT
Canaccord Genuity Starts Prestige Consumer Healthcare at Buy With $71 Price Target MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $63 From $68, Maintains Outperform Rating MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $68 From $63, Maintains Outperform Rating MT
ANALYST RECOMMENDATIONS : Edison International, Ford, General Motors, GSK, Upstart... Our Logo
Jefferies Upgrades Prestige Consumer Healthcare to Buy From Hold, Adjusts Price Target to $70 From $65 MT
DA Davidson Lowers Prestige Consumer Healthcare's Price Target to $60 From $63, Maintains Neutral Rating MT
Oppenheimer Upgrades Prestige Consumer Healthcare to Outperform From Perform, Sets $63 Price Target MT
DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps Neutral Rating MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $61 from $52, Keeps Neutral Rating MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $52 from $49, Keeps Neutral Rating MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $49 from $39, Keeps Neutral Rating MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $39 from $45, Maintains Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
70.47 USD
Average target price
74.33 USD
Spread / Average Target
+5.48%
High Price Target
84 USD
Spread / Highest target
+19.20%
Low Price Target
65 USD
Spread / Lowest Target
-7.76%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Prestige Consumer Healthcare Inc.

Oppenheimer
Canaccord Genuity
Jefferies & Co.
DA Davidson

Ratings for Prestige Consumer Healthcare Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PBH Stock
  4. Consensus Prestige Consumer Healthcare Inc.